Document is current
Any future updates will be listed below
-
Authors
Yamaguchi, Hiroki https://orcid.org/0000-0002-0571-7495
Takezako, Naoki
Ohashi, Kazuteru
Oba, Koji
Kumagai, Takashi
Kozai, Yasuji
Wakita, Hisashi
Yamamoto, Koh
Fujita, Akira
Igarashi, Tadahiko
Yoshida, Chikashi
Ohyashiki, Kazuma
Okamoto, Shinichiro
Sakamoto, Junichi
Sakamaki, Hisashi
Inokuchi, Koiti
- License Information
-
More Information
Article History
Received: 12 July 2019
Revised: 9 December 2019
Accepted: 10 December 2019
First Online: 1 January 2020
Compliance with ethical standards
:
: Hiroki Yamaguchi received honoraria from Novartis Co., Ltd., Kazuteru Ohashi received research support from Celgene Co., Ltd., Jansen Pharma Co., Ltd., Chugai Pharma Co., Ltd., Bristol-Myers Squibb Co., Ltd., Novartis Pharma Co., Ltd., and Kirin Co., Ltd., and served as consultant and advisor of Celgene Co., Ltd., Novartis Co., Ltd., Bristol-Myers Squibb Co., Ltd., and Ariad Co., Ltd., and honoraria from Novartis Co., Ltd., Bristol-Myers Squibb Co., Ltd., and Nippon Shinyaku Co., Ltd. Koji Oba received honoraria from Eisai Co., Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi-Sankyo Pharmaceutical Co., Ltd., Asahi Kasei Pharma Corp., Takeda Pharmaceuticals, Co., Ltd., and Ono Pharmaceutical Co., Ltd. Chikashi Yoshida received honoraria from Bristol-Myers Squibb Co., Ltd., Novartis Co., Ltd., Pfizer Co., Ltd., and Otsuka Pharmacology Co., Ltd.. Takashi Kumagai received honoraria from Bristol-Myers Squibb Co., Ltd., Novartis Co., Ltd., Pfizer Co., Ltd., and Otsuka Pharmacology Co., Ltd.. Shinichiro Okamoto received research support and honoraria from Novartis Co., Ltd., Bristol-Myers Squibb Co., Ltd., Pfizer Co., Ltd., and Otsuka Co., Ltd., Koiti Inokuchi received research support from Celgene Co., Ltd., Bristol-Myers Squibb Co., Ltd., and Ono Pharmaceutical Co., Ltd., and received honoraria from Novartis Co., Ltd., Bristol-Myers Squibb Co., Ltd., and Pfizer Co., Ltd.
